Related Experiment Video
Updated: Jan 6, 2026

07:23
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
8.9K
STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression.
Wei Ma1, Yingying Zhang2, Yu Qi3
1Hematology and Oncology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Archives of Medical Science : AMS
|October 2, 2019
Summary
Signal transducer and activator of transcription 3 (STAT3) promotes chronic lymphocytic leukemia (CLL) by increasing SMYD3 expression. Targeting STAT3 and SMYD3 may offer new therapeutic strategies for CLL patients.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Chronic lymphocytic leukemia (CLL) is a hematological malignancy.
- The roles of STAT3 and SMYD3 in CLL pathogenesis require further elucidation.
Purpose of the Study:
- To investigate the roles of STAT3 and SMYD3 in CLL.
- To determine the regulatory relationship between STAT3 and SMYD3 in CLL.
Main Methods:
- Gene expression analysis (RT-qPCR, Western blot) in CLL samples and cell lines.
- Gene knockdown (siRNA) and overexpression (plasmid) techniques.
- Functional assays including MTT (proliferation) and Transwell (invasion).
- Molecular mechanism validation using luciferase reporter and ChIP assays.
Main Results:
- STAT3 was upregulated in CLL cells.
- STAT3 knockdown reduced SMYD3 expression.
- STAT3 directly binds to the SMYD3 promoter, enhancing its transcription.
- STAT3 inhibition suppressed CLL cell proliferation and invasion.
- SMYD3 overexpression partially reversed the inhibitory effects of STAT3 knockdown.
Conclusions:
- STAT3 promotes CLL progression by upregulating SMYD3.
- The STAT3/SMYD3 axis represents a potential therapeutic target for CLL.
Related Concept Videos
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The JAK-STAT Signaling Pathway
11.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.7K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K

